Our Platform
Mission
Platform
Scientific Materials
LOWE
Pipeline
Clinical Trials
View All
FAP - TUPELO
Solid Tumors - ELUCIDATE
Solid Tumors & Lymphoma - DAHLIA
B-cell Malignancies - EXCELERIZE
Solid Tumors - ENLYGHT
Partners
Investors
Investor Relations
ESG
Download Day
Company Materials
About Us
Story
Team
News
Press
Blog
Careers
Programming biology: next-gen AI firms raise billions to design better medicines
May 26, 2026
Written By:
No items found.
Read the post ›
Decoding biology to radically improve lives.
®
Get In Touch
Get Involved
Policies
Connect
© 2025 Recursion. All rights reserved.
